VAYA Pharma recently relocated from the University of Maryland BioPark in Baltimore to Columbia.
The biotech company is a subsidiary of Israel-based Enzymotec Ltd. VAYA Pharma develops lipid-based medical foods, which are used to manage nutritional imbalances associated with diseases, including ADHD.
The company moved to the BioPark in 2016. The move came amid growth as the company sought a bigger space, said Chief Financial and Operating Officer Eyal Hen. VAYA Pharma now has 15 employees in Baltimore, and a total of 70 in the U.S.
READ FULL ARTICLE HERE
